ConductScience.org, home

Comparison · NCT00227877-e4739a4d

cSBA - New England, USA vs Control - New England, USA: Any Risky Riding or Driving at 12 Months - New England, USA

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. cSBA - New England, USA vs Control - New England, USA: Any Risky Riding or Driving at 12 Months - New England, USA. Trial comparisons, record NCT00227877-e4739a4d. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00227877-e4739a4d

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.1630.1390.191wilson
Risk in group 20.2130.1850.244wilson
Risk difference, group 1 minus group 2-0.0496-0.0888-0.0103newcombe hybrid score
Risk ratio, group 1 over group 20.7670.6210.947log
Odds ratio, group 1 over group 20.7220.5570.935log
Number needed to treat, for one fewer participant with the outcome on cSBA - New England, USA than on Control - New England, USA20.211.397.3from the risk difference interval

Groups2

Group 2 names the comparator: control.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1cSBA - New England, USA
Computer Screen \& Brief physician Advice: Participants in the experimental arm completed a computerized CRAFFT screen and received information on the computer regarding the health effects of substance use. Their provider was given the results of their CRAFFT screen and a list of suggested talking points which guided a discussion with the patient about drug and alcohol use.
125765OG001
Group 2Control - New England, USAControl participants received care as usual from their provider161756OG000

Outcome

Type
SECONDARY
Title
Any Risky Riding or Driving at 12 Months - New England, USA
Description
Any past-90-day self-reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs at 12 months post-baseline assessment - New England
Time frame
Past-90-days at 12 months post-baseline
Population
12-18 year old primary care patients in New England, USA

Source ClinicalTrials.gov

Trial

Title
Screening and Brief Advice to Reduce Teen Substance Use
NCT number
NCT00227877
Phases
NA
Conditions
Substance Related Disorders
Interventions
cSBA - New England, USA, cSBA - Prague, CZR
Lead sponsor
Boston Children's Hospital
Results first posted
2018-09-21

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00227877-e4739a4d